EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor
CHEBI:CHEBI_77108
Definition
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141).
Alternative Names
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors
- (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
- (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
- 11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
- 11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
- 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor
- 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors
- 15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor
- 15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors
- 15-hydroxyprostaglandin dehydrogenase inhibitor
- 15-hydroxyprostaglandin dehydrogenase inhibitors
- 15-hydroxyprostanoic dehydrogenase inhibitor
- 15-hydroxyprostanoic dehydrogenase inhibitors
- 15-OH-PGDH inhibitor
- 15-OH-PGDH inhibitors
- EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors
- EC 1.1.1.141 inhibitor
- EC 1.1.1.141 inhibitors
- NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor
- NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors
- NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor
- NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors
- PGDH inhibitor
- PGDH inhibitors
- prostaglandin dehydrogenase inhibitor
- prostaglandin dehydrogenase inhibitors
Drug Classification
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:77108
- oboInOwl#hasDbXref
- Wikipedia:15-hydroxyprostaglandin_dehydrogenase_(NAD%2B)
Additional References
Wikipedia:15-hydroxyprostaglandin_dehydrogenase_(NAD%2B)
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_16118
- owl#someValuesFrom
- t122405
- owl#annotatedSource
- t293852
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#id
- CHEBI:77108
- core#notation
- CHEBI:77108
- oboInOwl#hasDbXref
- Wikipedia:15-hydroxyprostaglandin_dehydrogenase_(NAD%2B)
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class